VTGN - ビスタジェン・セラピュ―ティクス （VistaGen Therapeutics Inc.） ビスタジェン・セラピュ―ティクスVTGNのチャート
VTGNの企業情報
| symbol | VTGN |
|---|---|
| 会社名 | VistaGen Therapeutics Inc （ビスタジェン・セラピュ―ティクス） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Major Pharmaceuticals |
| 業種 | 医薬品 医療関連（Health Care） |
| 概要 | 事業概要 ビスタジェン・セラピューティクス(VistaGen Therapeutics Inc.)はバイオテクノロジーの企業である。同社はヒト多能性幹細胞技術(hPSC技術)に従事する。同社は薬物救助、予測毒性学および薬物代謝のスクリーニングにおいてhPSC技術を応用している。同社の製品は「CardioSafe 3D」「LiverSafe 3D」「AV-101」を含む。同社は毒性と非毒性の両方の生体内心臓への影響を予測するための三次元(3D)ビトロバイオアッセイ系のCardioSafe 3Dの小分子薬剤候補を、動物と人間でのテストのかなり前に開発した。同社は、多能性幹細胞由来の成熟ヒト肝細胞を利用して肝臓毒性および薬物代謝の問題を評価するための3Dビトロバイオアッセイ系のLiverSafe 3Dを開発・検証している。AV-101は数十億ドルの神経疾患・障害市場を目指す経口投与可能な低分子プロドラッグ候補である。 ビスタジェン・セラピュ―ティクスは米国のバイオ医薬品企業。臨床ステ―ジで、中枢神経系疾患やがんに対する治療法の開発・商業化に従事する。同社は幹細胞技術プラットフォ―ムを利用し、薬物となる化学物質を特定し候補薬を開発する。主要製品候補「AV-101」は鬱病の治療薬である。本社はカリフォルニア州サウス・サンフランシスコ。 VistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing and commercializing innovative medicines with the potential to go beyond the current standard of care for anxiety, depression, and other CNS disorders. Each of VistaGen's three drug candidates has a differentiated potential mechanism of action, has been well-tolerated in all clinical studies to date, and has therapeutic potential in multiple CNS markets. |
| 本社所在地 | 343 Allerton Avenue South San Francisco CA 94080 USA |
| 代表者氏名 | H. Ralph Snodgrass H.ラルフ・スノッドグラス |
| 代表者役職名 | President Chief Scientific Officer Director |
| 電話番号 | +1 650-577-3600 |
| 設立年月日 | 38626 |
| 市場名 | NASDAQ Small Cap |
| ipoyear | ―年 |
| 従業員数 | 9人 |
| url | www.vistagen.com |
| nasdaq_url | https://www.nasdaq.com/symbol/vtgn |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -16.07700 |
| 終値（lastsale） | 1.82 |
| 時価総額（marketcap） | 46984419.3 |
| 時価総額 | 時価総額（百万ドル） 47.75889 |
| 売上高 | 売上高（百万ドル） 0.00000 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 40.72409 |
| 当期純利益 | 当期純利益（百万ドル） -17.55090 |
| 決算概要 | 決算概要 BRIEF: For the three months ended 30 June 2018 Vistagen Therapeutics Inc revenues was not reported. Net loss applicable to common stockholders increased 79% to $4.5M. Higher net loss reflects Research and development increase from $1.1M to $2.7M (expense) General and administrative increase of 26% to $1.5M (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$0.28 to -$0.20. |
VTGNのテクニカル分析
VTGNのニュース
Morning Stocks in Focus: VistaGen Therapeutics, Inc. (NASDAQ:VTGN), Stronghold Digital Mining, Inc. (NASDAQ:SDIG) 2023/02/27 17:18:37 Stock Equity
VTGN has seen its SMA50 which is now 4.46%. In looking the SMA 200 we see that the stock has seen a -51.87%. SDIG has seen its SMA50 which is … The post Morning Stocks in Focus: VistaGen Therapeutics, Inc. (NASDAQ:VTGN), Stronghold Digital Mining, Inc. (NASDAQ:SDIG) appeared first on Stocks Equity .
Morning Stocks to Keep Your Eyes on: Upstart Holdings, Inc. (NASDAQ:UPST), VistaGen Therapeutics, Inc. (NASDAQ:VTGN) 2023/02/24 18:16:15 Stock Equity
UPST has seen its SMA50 which is now 6.82%. In looking the SMA 200 we see that the stock has seen a -29.92%. VTGN has seen its SMA50 which is … The post Morning Stocks to Keep Your Eyes on: Upstart Holdings, Inc. (NASDAQ:UPST), VistaGen Therapeutics, Inc. (NASDAQ:VTGN) appeared first on Stocks Equity .
Analysts Believe VistaGen Therapeutics Inc. (NASDAQ: VTGN)’S Shares May Fall -38.89% 2023/02/22 15:30:00 Stocks Register
VistaGen Therapeutics Inc. (NASDAQ:VTGN) price closed lower on Tuesday, February 21, dropping -9.19% below its previous close. A look at the daily price movement shows that the last close reads $0.20, with intraday deals fluctuated between $0.177 and $0.193. The company’s 5Y monthly beta was ticking 1.03. Taking into account the 52-week price action we … Analysts Believe VistaGen Therapeutics Inc. (NASDAQ: VTGN)’S Shares May Fall -38.89% Read More »
Morning Stocks Under Consideration: VistaGen Therapeutics, Inc. (NASDAQ:VTGN -2.03%), WeTrade Group, Inc. (NASDAQ:WETG 3.57%) 2023/02/21 18:39:49 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Morning Stocks Under Consideration: VistaGen Therapeutics, Inc. (NASDAQ:VTGN -2.03%), WeTrade Group, Inc. (NASDAQ:WETG 3.57%) appeared first on Stocks Equity .
Powerful stocks to Increase Your Investments: VistaGen Therapeutics, Inc. (NASDAQ:VTGN 27.10%), BRF S.A. (NYSE:BRFS 9.60%) 2023/02/14 04:21:38 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Powerful stocks to Increase Your Investments: VistaGen Therapeutics, Inc. (NASDAQ:VTGN 27.10%), BRF S.A. (NYSE:BRFS 9.60%) appeared first on Stocks Equity .
Morning Stocks in Focus: VistaGen Therapeutics, Inc. (NASDAQ:VTGN), Stronghold Digital Mining, Inc. (NASDAQ:SDIG) 2023/02/27 17:18:37 Stock Equity
VTGN has seen its SMA50 which is now 4.46%. In looking the SMA 200 we see that the stock has seen a -51.87%. SDIG has seen its SMA50 which is … The post Morning Stocks in Focus: VistaGen Therapeutics, Inc. (NASDAQ:VTGN), Stronghold Digital Mining, Inc. (NASDAQ:SDIG) appeared first on Stocks Equity .
Morning Stocks to Keep Your Eyes on: Upstart Holdings, Inc. (NASDAQ:UPST), VistaGen Therapeutics, Inc. (NASDAQ:VTGN) 2023/02/24 18:16:15 Stock Equity
UPST has seen its SMA50 which is now 6.82%. In looking the SMA 200 we see that the stock has seen a -29.92%. VTGN has seen its SMA50 which is … The post Morning Stocks to Keep Your Eyes on: Upstart Holdings, Inc. (NASDAQ:UPST), VistaGen Therapeutics, Inc. (NASDAQ:VTGN) appeared first on Stocks Equity .
Analysts Believe VistaGen Therapeutics Inc. (NASDAQ: VTGN)’S Shares May Fall -38.89% 2023/02/22 15:30:00 Stocks Register
VistaGen Therapeutics Inc. (NASDAQ:VTGN) price closed lower on Tuesday, February 21, dropping -9.19% below its previous close. A look at the daily price movement shows that the last close reads $0.20, with intraday deals fluctuated between $0.177 and $0.193. The company’s 5Y monthly beta was ticking 1.03. Taking into account the 52-week price action we … Analysts Believe VistaGen Therapeutics Inc. (NASDAQ: VTGN)’S Shares May Fall -38.89% Read More »
Morning Stocks Under Consideration: VistaGen Therapeutics, Inc. (NASDAQ:VTGN -2.03%), WeTrade Group, Inc. (NASDAQ:WETG 3.57%) 2023/02/21 18:39:49 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Morning Stocks Under Consideration: VistaGen Therapeutics, Inc. (NASDAQ:VTGN -2.03%), WeTrade Group, Inc. (NASDAQ:WETG 3.57%) appeared first on Stocks Equity .
Powerful stocks to Increase Your Investments: VistaGen Therapeutics, Inc. (NASDAQ:VTGN 27.10%), BRF S.A. (NYSE:BRFS 9.60%) 2023/02/14 04:21:38 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Powerful stocks to Increase Your Investments: VistaGen Therapeutics, Inc. (NASDAQ:VTGN 27.10%), BRF S.A. (NYSE:BRFS 9.60%) appeared first on Stocks Equity .
Is VistaGen Therapeutics Inc. (NASDAQ) Bullish Or Bearish In 2022? 2022/10/28 14:30:00 Stocks Register
VistaGen Therapeutics Inc. (NASDAQ:VTGN) shares, rose in value on Thursday, 10/27/22, with the stock price up by 6.71% to the previous day’s close as strong demand from buyers drove the stock to $0.12. Actively observing the price movement in the last trading, the stock closed the session at $0.11, falling within a range of $0.1125 … Is VistaGen Therapeutics Inc. (NASDAQ) Bullish Or Bearish In 2022? Read More »
Watch this stock’s price performance: VistaGen Therapeutics Inc. (NASDAQ:VTGN) 2022/10/07 16:48:00 US Post News
VistaGen Therapeutics Inc. (VTGN)’s stock is trading at $0.15 at the moment marking a fall of -4.46% from the last session close. As of this writing, shares are priced at -94.42% less than their 52-week high of $2.69, and 8.07% over their 52-week low of $0.14. Based on the past 30-day period, the stock price […]
Vistagen Announces the Two Leading Proxy Advisory Firms, Institutional Shareholder Services and Glass Lewis, Recommend Stockholders Vote “FOR” Proposal No. 5 to Provide its Board with the Option to Implement a Future Reverse Stock Split, if Necessary 2022/10/06 12:30:00 Wallstreet:Online
Vistagen Therapeutics, Inc. (Nasdaq: VTGN) (the Company), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (CNS) disorders, today announced that the two leading independent proxy advisory firms, Institutional Shareholder Services Inc. (ISS) and Glass Lewis & Co. (Glass Lewis),
Wondrous stocks: VistaGen Therapeutics, Inc. (NASDAQ:VTGN -4.86%), Nielsen Holdings plc (NYSE:NLSN 0.11%) 2022/09/20 23:59:03 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Wondrous stocks: VistaGen Therapeutics, Inc. (NASDAQ:VTGN -4.86%), Nielsen Holdings plc (NYSE:NLSN 0.11%) appeared first on Stocks Equity .
Why SciSparc Is Trading Higher By 68%, Here Are 48 Stocks Moving In Wednesday''s Mid-Day Session 2022/09/14 16:28:41 Benzinga
Gainers Akerna Corp. (NASDAQ: KERN ) shares rose 81.2% to $0.2355 after gaining 8% on Tuesday. SciSparc Ltd. (NASDAQ: SPRC ) gained 68% to $1.3101 after the company announced it entered into an agreement to acquire Wellution for $20 million. bioAffinity Technologies, Inc. (NASDAQ: BIAF ) shares jumped 51.2% to $6.27 after the company announced publication of its research in high-throughput flow cytometry analysis of sputum in PLOS ONE. My Size, Inc. (NASDAQ: MYSZ ) rose 44% to $0.3194. ThermoGenesis Holdings, Inc. (NASDAQ: THMO ) surged 36.8% to $0.3090. Avenue Therapeutics, Inc. (NASDAQ: ATXI ) jumped 28.6% to $0.2992. Fast Radius, Inc. (NASDAQ: FSRD ) gained 23.6% to $0.6799. NeuroOne Medical Technologies Corporation (NASDAQ: NMTC ) rose 23% to $2.2269. VistaGen Therapeutics, Inc. (NASDAQ: VTGN ) jumped 19.6% to $0.2259. VistaGen Therapeutics recently announced the completion of an interim analysis of its PALISADE-2 Phase 3 clinical trial of PH94B. Tenax Therapeutics, Inc. (NASDAQ: TENX ) surged 18% to $0.24.